SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-019604
Filing Date
2023-05-09
Accepted
2023-05-09 16:02:04
Documents
14
Period of Report
2023-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rxdx-20230509.htm   iXBRL 8-K 68175
2 EX-99.1 rxdx-ex99_1.htm EX-99 168385
3 GRAPHIC img78415819_0.jpg GRAPHIC 17601
  Complete submission text file 0000950170-23-019604.txt   392254

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rxdx-20230509_pre.xml EX-101.PRE 10691
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rxdx-20230509.xsd EX-101.SCH 2501
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rxdx-20230509_lab.xml EX-101.LAB 16995
8 EXTRACTED XBRL INSTANCE DOCUMENT rxdx-20230509_htm.xml XML 4533
Mailing Address 3050 SCIENCE PARK ROAD SAN DIEGO CA 92121
Business Address 3050 SCIENCE PARK ROAD SAN DIEGO CA 92121 (858) 422-4300
Prometheus Biosciences, Inc. (Filer) CIK: 0001718852 (see all company filings)

IRS No.: 814282653 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40187 | Film No.: 23901794
SIC: 2834 Pharmaceutical Preparations